Transradial Access Devices Market Research Report – Forecast to 2027

Transradial Access Devices Market Research Report: By Product (Catheters, Guidewires), Application (Drug Administration, Blood Transfusion), Disease Area (Cardiovascular Diseases, Cancer, Stroke), End-User (Hospitals, Clinics) – Forecast Till 2027

ID: MRFR/MED/4603-HCR | August 2022 | Region: Global | 100 Pages         

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Transradial Access Devices Market, By Product

6.1 Introduction

6.2 Catheters

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

6.3.1 Cardiovascular Catheters

6.3.2 Specialty Catheters

6.3.3 Intravenous Catheters

6.3.4 Urinary Catheters

6.3.5 Neurological Catheters

6.3 Guidewires

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

6.3.1 Solid Guidewire

6.3.2 Wrapped Guidewire

6.4 Sheaths & Sheath Introducers

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

6.5 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

7. Global Transradial Access Devices Market, By Application

7.1 Introduction

7.2 Drug Administration

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

7.3 Fluid And Nutrition Administration

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

7.4 Blood Transfusion

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

7.4 Diagnostics & Testing

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

8. Global Transradial Access Devices Market, By Disease Area

8.1 Introduction

8.2 Cardiovascular Diseases

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

8.3 Cancer

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

8.4 Rheumatoid Arthritis

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

8.5 Endometriosis

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

8.6 Ischemic Stroke

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

8.7 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

9. Global Transradial Access Devices Market, By End-User

9.1 Introduction

9.2 Hospitals

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

9.3 Clinics

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

9.4 Ambulatory Care Centers

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

9.4 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, By Region/Country, 2020–2027

10 Global Transradial Access Devices Market, By Region

10.1 Introduction

10.2 Americas

• Market Estimates & Forecast, By Region, 2020–2027

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.2.1 North America

• Market Estimates & Forecast, By Country, 2020–2027

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.2.1.1 U.S.

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.2.1.2 Canada

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.2.2 South America

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3 Europe

• Market Estimates & Forecast, By Region, 2020–2027

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1 Western Europe

• Market Estimates & Forecast, By Country, 2020–2027

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1.1 Germany

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1.2 France

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1.3 U.K.

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1.4 Italy

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1.5 Spain

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.1.6 Rest Of Western Europe

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.3.2 Eastern Europe

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4 Asia Pacific

• Market Estimates & Forecast, By Country, 2020–2027

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4.1 Japan

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4.2 China

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4.3 India

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4.4 Australia

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4.5 Republic Of Korea

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.4.6 Rest Of Asia Pacific

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5 The Middle East & Africa

• Market Estimates & Forecast, By Region, 2020–2027

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5.1 United Arab Emirates

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5.2 Saudi Arabia

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5.3 Oman

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5.4 Kuwait

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5.5 Qatar

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

10.5.6 Rest Of The Middle East & Africa

• Market Estimates & Forecast, By Product, 2020–2027

• Market Estimates & Forecast, By Application, 2020–2027

• Market Estimates & Forecast, By Disease Area, 2020–2027

• Market Estimates & Forecast, By End-User, 2020–2027

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Becton, Dickinson And Company

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Terumo Corporation

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Teleflex Incorporated

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Smiths Group Plc

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Edward Lifesciences Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 Medtronic Plc

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Merit Medical System

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Boston Scientific Corporation

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 NIPRO Medical Corporation

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 AngioDynamics

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Ameco Medical Industries

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 OSCOR Inc.

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 ARROW International CR, A.S

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 C.R. Bard

12.14.1 Overview

12.14.2 Product Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Stryker Corporation

12.15.1 Overview

12.15.2 Product Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

13 Appendix

 

LIST OF TABLES

Table 1 Transradial Access Devices Industry Synopsis, 2020–2027

Table 2 Global Transradial Access Devices Market Estimates And Forecast, 2020–2027, (USD Million)

Table 3 Global Transradial Access Devices Market, By Region, 2020–2027, (USD Million)

Table 5 Global Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 5 Global Transradial Access Devices Market, By Application, 2020–2027, (USD Million)

Table 6 Global Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 7 Global Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 8 North America Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 9 North America Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 9 North America Transradial Access Devices Market, By Application, 2020–2027, (USD Million)

Table 10 North America Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 11 U.S. Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 12 U.S. Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 12 U.S. Transradial Access Devices Market, By Application, 2020–2027, (USD Million)

Table 13 U.S. Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 14 Canada Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 14 Canada Transradial Access Devices Market, By Application, 2020–2027, (USD Million)

Table 15 Canada Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 16 Canada Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 17 South America Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 18 South America Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 19 South America Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 20 Europe Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 21 Europe Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 22 Europe Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 23 Western Europe Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 24 Western Europe Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 25 Western Europe Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 26 Eastern Europe Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 27 Eastern Europe Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 28 Eastern Europe Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 29 Asia Pacific Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 30 Asia Pacific Transradial Access Devices Market, By Disease Area, 2020–2027, (USD Million)

Table 31 Asia Pacific Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

Table 32 Middle East & Africa Transradial Access Devices Market, By Product, 2020–2027, (USD Million)

Table 33 Middle East & Africa Transradial Access Devices Market, By Application, 2020–2027, (USD Million)

Table 34 Middle East & Africa Transradial Access Devices Market, By End-User, 2020–2027, (USD Million)

 

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Transradial Access Devices Market

Figure 3 Segmentation Market Dynamics For Transradial Access Devices Market

Figure 4 Global Transradial Access Devices Market Share, By Product 2020

Figure 5 Global Transradial Access Devices Market Share, By Application 2020

Figure 6 Global Transradial Access Devices Market Share, By End-User, 2020

Figure 7 Global Transradial Access Devices Market Share, By Region, 2020

Figure 8 North America Transradial Access Devices Market Share, By Country, 2020

Figure 9 Europe Transradial Access Devices Market Share, By Country, 2020

Figure 10 Asia Pacific Transradial Access Devices Market Share, By Country, 2020

Figure 11 Middle East & Africa Transradial Access Devices Market Share, By Country, 2020

Figure 12 Global Transradial Access Devices Market: Company Share Analysis, 2020 (%)

Figure 13 Becton, Dickinson And Company: Key Financials

Figure 14 Becton, Dickinson And Company: Segmental Revenue

Figure 16 Becton, Dickinson And Company: Geographical Revenue

Figure 17 Teleflex Incorporated. Key Financials

Figure 18 Teleflex Incorporated: Segmental Revenue

Figure 19 Teleflex Incorporated: Geographical Revenue

Figure 20 Ortho Clinical Diagnostics: Key Financials

Figure 21 Ortho Clinical Diagnostics: Segmental Revenue

Figure 22 Ortho Clinical Diagnostics: Geographical Revenue

Figure 23 Smiths Group Plc: Key Financials

Figure 24 Smiths Group Plc: Segmental Revenue

Figure 25 Smiths Group Plc: Geographical Revenue

Figure 26 Siemens Healthcare Diagnostics: Key Financials

Figure 27 Siemens Healthcare Diagnostics: Segmental Revenue

Figure 28 Siemens Healthcare Diagnostics. Geographical Revenue

Figure 29 Terumo Corporation. Key Financials

Figure 30 Terumo Corporation. Segmental Revenue

Figure 31 Terumo Corporation. Geographical Revenue

Transradial Access Market

The global Transradial Access Market is projected to reach USD 2.18 Billion at a CAGR of 7.5% during the forecast period of 2022-2030

$2.18 Billion

Market Size


7.5%

CAGR


North America

Dominating Region

2022-2030

Forecast Period

Segmentation

By Product Catheters Guidewires
By Application Drug Administration Blood Transfusion
By Disease Area Cardiovascular Diseases Cancer Stroke
By End-User Hospitals Clinics

Key Players

  • Becton
  • Dickinson and Company (U.S.)
  • Terumo Corporation (Japan)
  • Teleflex Incorporated (US)
  • Smiths Group Plc (UK)
  • Edward Lifesciences Corporation (US)
  • Medtronic Plc (Ireland)

Drivers

  • Increasing cardio-related procedures such as angioplasties
Speak to Analyst Request a Free Sample

Transradial Access Devices Market Overview:


Transradial access devices market is anticipated to register a CAGR of 7.5% during the forecast period of 2018–2023. The Transradial Access Devices are intensively utilized in the healthcare market for diagnosis or treatment related to arterial disease. The transradial access to the coronary arteries reduces bleeding and vascular complications when compared with transfemoral artery access. Primary procedures include percutaneous stenting, angiography, and angioplasty. The procedure is carried out when the patient is experiencing chest pain very often to examine the patient’s coronary arteries. The procedure is carried with the help of the inflation of the balloon. The balloon being attached to the tip of the catheter is sent inside the blocked arteries. Once the balloon is placed at the right position, it is inflated to press against the plague which eventually pushes the plague to the side of the blood vessels; thereby blood flow in the arteries is brought back to normal.  


Recent studies show that the transradial access method has significantly reduced over 70% of blood loss during surgery. The increasing prevalence of chronic illness and obesity have stimulated cardiac arrests and similar conditions. Such factors are fueling the growth of the Transradial Access Devices industry in recent years.


COVID 19 Analysis:


The COVID pandemic has affected a large segment of industries and commercial activities. The health care industry is also significantly affected by the pandemic hit. The fear of getting infected by visiting hospitals, restrictions in movements have reduced the surgeries. On the other hand, virtual consultations and telehealth health care solutions are paving way for the growth of the Transradial Access Devices industry. 


The COVID -19 widespread has significantly affected the cardio-related services and workflow in health care centers. Especially, the health care workers in the hospitals are affected significantly. COVID-positive patients tend to show up ECG changes and myopericarditis which mimic the ACS condition. Such factors have affected the overall growth of the Transradial access devices industry during this pandemic.


Transradial Access Devices Market Dynamics:


Drivers:


The changing lifestyle and attitude across the globe has caused several cardiovascular diseases and increased the prevalence of obesity in recent times. Additionally, increasing demand for minimally invasive surgical procedures in the developed countries is the major driving factor for the growth of the Transradial Access Devices industry.


Increasing cardio-related procedures such as angioplasties, administrating drugs through veins, diagnostics, administrating fluids via IVs can be done with the help of Transradial Access Devices. Such practices have aided the overall growth of the Transradial Access Devices industry in recent times.


Opportunities:


With the increasing inclination towards Transradial Access Devices procedures for surgeries and other procedures, the demand for the growth of the Transradial access devices market is booming in the health care industries. Health conditions such as Obesity, which is considered a major health issue globally involves several diagnoses frequently. Diabetes, which is known as a life-threatening chronic illness, and its increasing prevalence in recent years are some major factors that provide lucrative opportunities for the growth of the Transradial access devices market.


The cost comparison between the transfemoral procedures and transradial approach has a vast difference, which propels the healthcare administers to choose the Transradia devices for crucial diagnosis and treatments. Especially, the costs of specialized sheaths, wires, and catheters might seem more costly, but the post-procedure costs are extremely lower when compared with other procedures. Lower bed recovery time, lower incidences of bleeding during the procedure, lower cardiovascular complications are providing the major opportunities for the growth of the Transradial Access Devices industry.


Market restraints:


Stringent regulations imposed by the medical association, poor reimbursement policies, and higher costs incurred during the procedures are some of the major market restraints. 


Maintenance of devices, repetitive friction during the process, and access failure are considered as the major restraining factors in the growth of the Transradial access devices market.


Market challenges:


Performing cardiac catheterization through the radial artery is considered the major challenge. Obtaining access through the radial artery when the artery tends to spasm during the procedure complicates the procedure. 


Catheter manipulation is also considered a challenge; improper sheath sizes can complicate the manipulation of catheters. Especially, variation in the forearm arterial anatomy doesn’t permit the catheters to traverse through them, although the coronary catheters are extremely flexible.


Cumulative growth analysis:


The cardio diagnosis is increasing in recent times, improper diet, lack of exercise, growing work-from-home trends and sedentary lifestyle are leading to life-threatening conditions such as obesity, diabetes, cardiovascular diseases, cardiac arrests, and blockage of arteries. However, the Transradial Access Devices are prevalently used in various other procedures like chemotherapy, cardio diagnosis, and so on. Transradial Access Devices market is expected to register a CAGR of 7.8% during the forecast period. 


The comfort level of the patients is increased as compared to other traditional methods. Moreover, the hospital stay after the procedure and recovery are favorable for the patients who undergo Transradial access procedures. Advancing health care infrastructure in the developed countries and effective medication and medical recommendations have promoted the overall Transradial Access Devices market growth.


Value chain analysis:


The Transradial Access Devices market growth is primarily due to the advantages associated with the transradial approach of treating medical conditions. The earlier ambulation times, reduced usage of clamps to hold the skin, higher patient satisfaction, improved living condition, and higher costs savings are the major benefits of the transradial access approach. Additionally, the post-operation observation is minimal, the patients are usually discharged on the same day, and accuracy in results and effective diagnosis, chemotherapy is carried out using the appropriate Transradial Devices. 


The procedure has the major challenge of acquiring artery spasm, which is handled with the help of administrating a 5 mg dosage of verapamil to reduce the spasm; a milder dosage of heparin is injected to combat the thrombosis condition. A multi-purpose catheter or tiger catheter is utilized for ventriculography and coronary angiography. For the diagnosis of angiography, the success rate is over 90% which makes it more preferable than the femoral approach. 


Transradial Access Devices Market Segment Overview:


Based on Product:



  • Catheters

  • Guide wires

  • Sheaths, Sheath introducers

  • Accessories                                                                                        


Based on application:



  • Drug administration

  • Fluid and Nutrition Administration

  • Blood transfusion

  • Diagnostics and testing


Based on End-users:



  • Hospitals

  • Clinics and ambulatory care centers

  • Others


Transradial Access Devices Market Regional analysis:


Over other regions, North America is holding the largest market share owing to the increasing prevalence of cardiovascular diseases in the region. Life-threatening conditions such as HIV/AIDS are increasing in the region which requires frequent diagnosis; such factors are propelling the demand for the Transradial access devices market. Moreover, a recent study in Japan has shown that there is over 28% of the geriatric population in the country. This factor has increased the patient admission with coronary diseases. Hence Japan is expected to hold a market share of over 25.5% in the forecast period. 


Technological advancements in Japan, favorable reimbursement policies in Australia, increasing governmental support in countries like Latin America, Middle Eastern countries, and Africa are some of the favorable conditions for the overall growth of the Transradial Access Devices industry in such regions. 


Transradial Access Devices Market Competitive Landscape:



  • Becton

  • Dickinson and Company

  • Terumo Corporation

  • Teleflex Incorporated

  • Smith’s Medical

  • Medtronic

  • Edward Lifesciences Corporation

  • Merit Medical Systems

  • Boston Scientific Corporation

  • Nipro Medical Corporation

  • Angiodynamics, Inc.


Recent developments:


The guidance obtained from the ultrasound radiations is found to facilitate vascular access in setting the weak pulse in the patients who possess prohibitive RA anatomy. The combination of effective usage of sheaths and ultrasound radiations is found to be effective in primary diagnosis.


To reduce the discomfort level, medical practitioners have started using Low-profile hydrophilic sheathes in recent times. This technique has prevented RA spasms and thereby provided effective diagnosis thorough out the procedure. Additionally, usage of intra-arterial vasodilators is utilized to combat the condition during the procedure.


Report Overview:


This report has covered:



  • Market overview

  • COVID 19 Analysis

  • Market dynamics

  • Cumulative growth analysis

  • Value chain analysis

  • Segment overview

  • Regional analysis

  • Competitive landscape

  • Recent developments

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Transradial Access Devices Market is projected to grow at a 7.5% CAGR between 2018-2023.

The Americas is expected to lead the Transradial Access Devices Market.

It is widely used in diagnostics and testing, blood transfusion, drug administration, and others.

Increasing prevalence of obesity and rising number of chemotherapy procedures are adding market growth.

Product recalls and high costs may limit market growth.